Global /Germany /Healthcare /Drug Manufacturers - Specialty & Generic /APPH

Apontis Pharma AG

APPH

• XETRA: APPH • Delayed

11.00EUR 0%

12.78 USD

As of 5 June 2026, Apontis Pharma AG has a market cap of $106.43M USD, ranking #25117 globally and #273 in Germany. It ranks #2251 in the Healthcare sector, and #117 in the Drug Manufacturers - Specialty & Generic industry.

Global Rank

25117

Country Rank

273

Sector Rank

2251

Industry Rank

117

Key Stats

Market Cap

$106.43MUSD

91.63M EUR

Enterprise Value

$93.21MUSD

80.25M EUR

Revenue (TTM)

$60.13MUSD

51.77M EUR

EBITDA (TTM)

$3.23MUSD

2.78M EUR

Net Income (TTM)

$760.22KUSD

654.52K EUR

EBITDA Margin

5.4%

Profit Margin

1.3%

PE Ratio

140.0

Forward PE

34.4

PS Ratio

1.8

PB Ratio

2.9

EV/EBITDA

28.8

Company Profile

Country (HQ)

Germany

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Sascha Glanemann open_in_new

Employees

137

Founded

1946

Website

apontis-pharma.de open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0%	0.9%	1.4%	1.4%	-1.8%	9.5%	13%	39%	-42%

News

Markets

Exchange	Ticker	Price	Quotes
Deutsche Börse Xetra (XETRA) MIC: XETR PRIMARY	APPH Apontis Pharma AG Bearer Shares ISIN: DE000A3CMGM5 Shares Out.: Shares Outstanding: 8.33M¹ Shares Float: 5.165M² TV: TradingView: XETR: APPH SA: Stock Analysis: ETR: APPH YF: Yahoo Finance: APPH.DE GF: Google Finance: FRA: APPH BA: Barron's: APPH MS: Morningstar: XETR: APPH	11.00 EUR	TV: TradingView: XETR: APPH SA: Stock Analysis: ETR: APPH YF: Yahoo Finance: APPH.DE GF: Google Finance: FRA: APPH BA: Barron's: APPH MS: Morningstar: XETR: APPH
Frankfurt Stock Exchange (FRA) MIC: XFRA	APPH Apontis Pharma AG Bearer Shares ISIN: DE000A3CMGM5 TV: TradingView: FWB: APPH SA: Stock Analysis: FRA: APPH YF: Yahoo Finance: APPH.F GF: Google Finance: FRA: APPH BA: Barron's: APPH MS: Morningstar: XFRA: APPH	11.00 EUR	TV: TradingView: FWB: APPH SA: Stock Analysis: FRA: APPH YF: Yahoo Finance: APPH.F GF: Google Finance: FRA: APPH BA: Barron's: APPH MS: Morningstar: XFRA: APPH

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Apontis Pharma AG

Apontis Pharma AG markets and sells medical drugs for indication fields of internal medicine in Germany. It offers single pills and other pharmaceutical products with a focus on cardiovascular diseases, such as hypertension, dylipidemia, secondary prophylaxis, and asthma, as well as respiratory diseases and diabetes. The company was founded in 1946 and is based in Monheim am Rhein, Germany. Apontis Pharma AG operates as a subsidiary of Zentiva AG.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (Germany)

Name	Market Cap (USD) diff.	PE	Country
PharmaSGP Holding SE XETRA: PSG	$401.15M 345.38M EUR 277%	17.5	Germany

Industry: Drug Manufacturers - Specialty & Generic (Global)

Name	Market Cap (USD) diff.	PE	Country
Teva Pharmaceutical Industries Ltd. TLV: TEVA	$37.66B 108.92B ILS 35K%	24.2	Israel
Revolution Medicines, Inc. NASDAQ: RVMD	$29.56B 28K%	-	United States
Zhejiang NHU Company Ltd. SHE: 002001	$15.86B 107.34B CNY 15K%	16.0	China
Cipla Ltd. NSE: CIPLA	$11.12B 1.06T INR 10K%	23.4	India
Lupin Ltd. NSE: LUPIN	$11.0B 1.05T INR 10K%	22.7	India
Haisco Pharmaceutical Group Co., Ltd. SHE: 002653	$9.1B 61.6B CNY 8K%	80.6	China

chevron_leftBack